IP Verse

Modified Rna With Decreased Immunostimulatory Properties - EP3062798

The patent EP3062798 was granted to Curevac on May 6, 2020. The application was originally filed on Oct 31, 2014 under application number EP14809289A. The patent is currently recorded with a legal status of "Revoked".

EP3062798

CUREVAC
Application Number
EP14809289A
Filing Date
Oct 31, 2014
Status
Revoked
Feb 21, 2025
Grant Date
May 6, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WEINZIERLFeb 8, 2021SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
WEICKMANN & WEICKMANNFeb 5, 2021-ADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2011275793
DESCRIPTIONWO02098443
DESCRIPTIONWO2007024708
DESCRIPTIONWO2008077592
DESCRIPTIONWO2011012316
DESCRIPTIONWO2011071931
DESCRIPTIONWO2011130624
DESCRIPTIONWO2013052523
INTERNATIONAL-SEARCH-REPORTWO02098443
INTERNATIONAL-SEARCH-REPORTWO2006049777
INTERNATIONAL-SEARCH-REPORTWO2007024708
INTERNATIONAL-SEARCH-REPORTWO2009127230
OPPOSITIONWO02098443
OPPOSITIONWO2009127230
OPPOSITIONWO2015062738

Non-Patent Literature (NPL) Citations (71) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ANDERSON ET AL., NUCLEIC ACIDS RES., (2010), vol. 38, no. 17, pages 5884 - 92-
DESCRIPTION- ANDERSON ET AL., NUCLEIC ACIDS RES., (2011), vol. 39, no. 21, pages 9329 - 38-
DESCRIPTION- ARBINI ET AL., BLOOD, (1996), vol. 87, pages 5085 - 94-
DESCRIPTION- BEUTLER ET AL., The Metabolic and Molecular Bases of Inherited Disease, MCGRAW-HILL, pages 3635 - 3668-
DESCRIPTION- BISHOP ET AL., AM. J. HUM. GENET., (1985), vol. 37, page A144-
DESCRIPTION- BISHOP ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 4859 - 4863-
DESCRIPTION- BRADFORD ET AL., BIOCHEM. J., (1999), vol. 341, pages 193 - 201-
DESCRIPTION- BRADY ET AL., N. ENGL. J. MED., (1967), vol. 276, pages 1163 - 1167-
DESCRIPTION- BROZ ET AL., NAT. REV. IMMUNOL., (2013), vol. 13, no. 8, pages 551 - 65-
DESCRIPTION- CALHOUN ET AL., PROC. NATL. ACAD SCI. USA, (1985), vol. 82, pages 7364 - 7368-
DESCRIPTION- CHESSLER ET AL., J. BIOL. CHEM., (1993), vol. 268, pages 18226 - 18233-
DESCRIPTION- DAVIES ET AL., BUR. J. HUM. GENET., (1996), vol. 4, pages 219 - 224-
DESCRIPTION- DESMET ET AL., NAT. REV. IMMUNOL., (2012), vol. 12, no. 7, pages 479 - 91-
DESCRIPTION- DESNICK ET AL., The Metabolic and Molecular Bases of Inherited Disease, MCGRAW-HILL, (2001), pages 3733 - 3774-
DESCRIPTION- DUAN; JEFCOATE, J. MOL. ENDOCRINOL., (2007), vol. 38, no. 1-2, pages 159 - 79-
DESCRIPTION- ENG ET AL., AM. J. HUM. GENET., (1993), vol. 53, pages 1186 - 1197-
DESCRIPTION- ENG ET AL., MOL. MED., (1997), vol. 3, pages 174 - 182-
DESCRIPTION- E.W. MARTIN, Remington's Pharmaceutical Sciences-
DESCRIPTION- FOTIN-MLECZEK ET AL., J. IMMUNOTHER., (2011), vol. 34, no. 1, pages 1 - 15-
DESCRIPTION- GUIDELINES MEDICINAL PRODUCTS FOR HUMAN USE SAFETY, ENVIRONMENT AND INFORMATION EXCIPIENTS IN THE LABEL AND PACKAGE LEAFLET OF MEDICINAL PRODUCTS FOR HUMAN USE, (200307), vol. 3B-
DESCRIPTION- HALABAN ET AL., PROC. NATL. ACAD. SCI. USA., (2000), vol. 97, pages 5889 - 94-
DESCRIPTION- HOLCIK ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 2410 - 2414-
DESCRIPTION- KARIKO ET AL., CURR. OPIN. DRUG DISCOV DEVEL., (2007), vol. 10, no. 5, pages 523 - 32-
DESCRIPTION- KARIKO ET AL., IMMUNITY, (2005), vol. 23, no. 2, pages 165 - 75-
DESCRIPTION- KARIKO ET AL., MOL. THER., (2012), vol. 20, no. 5, pages 948 - 53-
DESCRIPTION- KARIKO ET AL., MOL. THER., vol. 20, no. 5, pages 948 - 53-
DESCRIPTION- KARIKO ET AL., NUCLEIC ACIDS RES., (2011), vol. 39, no. 21, page E142-
DESCRIPTION- KATO ET AL., BLOOD, (1992), vol. 79, pages 3212 - 8-
DESCRIPTION- KATSUMI ET AL., BLOOD, (1996), vol. 87, pages 4164 - 75-
DESCRIPTION- KAUSHAL ET AL., BIOCHEMISTRY, (1994), vol. 33, pages 6121 - 8-
DESCRIPTION- KORMANN ET AL., NAT. BIOTECHNOL., (2011), vol. 29, no. 2, pages 154 - 7-
DESCRIPTION- KORMANN, NAT. BIOTECHNOL., (2011), vol. 29, no. 2, pages 154 - 7-
DESCRIPTION- KORNREICH ET AL., NUCLEIC ACIDS RES., (1989), vol. 17, pages 3301 - 3302-
DESCRIPTION- KOZAK, MOL CELL BIOL., (198911), vol. 9, no. 11, pages 5073 - 80-
DESCRIPTION- MARQUARDT ET AL., EUR. J. CELL. BIOL., (1995), vol. 66, pages 268 - 273-
DESCRIPTION- NAKAO ET AL., N. ENGL. J. MED., (1995), vol. 333, pages 288 - 293-
DESCRIPTION- RAMAZOTTI ET AL., IN SILICO BIOL., (2007), vol. 7, no. 4-5, pages 507 - 26-
DESCRIPTION- ROBBINS ET AL., OLIGONUCLEOTIDES, (2009), vol. 19, no. 2, pages 89 - 102-
DESCRIPTION- SCHLAKE ET AL., RNA BIOL., (2012), vol. 9, no. 11, pages 1319 - 30-
DESCRIPTION- SELKOE, ANNU. REV. NEUROSCI., (1994), vol. 17, pages 489 - 517-
DESCRIPTION- SHARP ET AL., VIROLOGY, (1999), vol. 257, no. 2, pages 303 - 13-
DESCRIPTION- SHARP; LI, NUCLEIC ACIDS RES., (19870211), vol. 15, no. 3, pages 1281 - 95-
DESCRIPTION- The Metabolic and Molecular Bases of Inherited Disease, MCGRAW-HILL, (1995), pages 2529 - 2561-
DESCRIPTION- The Metabolic and Molecular Bases of Inherited Disease, MCGRAW-HILL, (2001), pages 3733 - 3774-
DESCRIPTION- The Metabolic and Molecular Bases of Inherited Disease, MCGRAW-HILL, pages 3589 - 3610-
DESCRIPTION- THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE, pages 3389 - 3420-
DESCRIPTION- THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE, pages 3421 - 3452-
DESCRIPTION- THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE, pages 3733 - 3774-
DESCRIPTION- THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE, pages 3775 - 3810-
DESCRIPTION- TSUJI ET AL., BUR. J. BIOCHEM., (1987), vol. 165, pages 275 - 280-
DESCRIPTION- WALTER ET AL., AM J HUM GENET, (2001), vol. 69, pages 35 - 48-
DESCRIPTION- WARREN ET AL., CELL STEM CELL, (2010), vol. 7, no. 5, pages 618 - 30-
DESCRIPTION- WEISMANN ET AL., SCIENCE, (1970), vol. 169, pages 72 - 74-
DESCRIPTION- ZÃœST ET AL., NAT. IMMUNOL., (2011), vol. 12, no. 2, pages 137 - 43-
EXAMINATION- Jiajie Wei ET AL, "The Stringency of Start Codon Selection in the Filamentous Fungus Neurospora crassa", Journal of Biological Chemistry, US, (20130329), vol. 288, no. 13, doi:10.1074/jbc.M112.447177, ISSN 0021-9258, pages 9549 - 9562, XP055561136
EXAMINATION- CÉLIMÈNE GALIGER ET AL, "Assessment of Efficacy of Antifungals against Aspergillus fumigatus: Value of Real-Time Bioluminescence Imaging", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, US, (20130711), vol. 57, no. 7, doi:10.1128/AAC.01660-12, ISSN 0066-4804, pages 3046 - 3059, XP055561132
INTERNATIONAL-SEARCH-REPORT- KARIKO ET AL., CURR. OPIN. DRUG DISCOV DEVEL., (2007), vol. 10, no. 5, pages 523 - 32, XP009154595 [AD] 1-21-
INTERNATIONAL-SEARCH-REPORT- K.-J. KALLEN ET AL, "A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs", THERAPEUTIC ADVANCES IN VACCINES, (20131106), vol. 2, no. 1, doi:10.1177/2051013613508729, ISSN 2051-0136, pages 10 - 31, XP055126338
INTERNATIONAL-SEARCH-REPORT- KARL-JOSEF KALLEN ET AL, "A novel, disruptive vaccination technology: Self-adjuvanted RNActive vaccines", HUMAN VACCINES & IMMUNOTHERAPEUTICS, (20131001), vol. 9, no. 10, doi:10.4161/hv.25181, ISSN 2164-5515, pages 16 - 29, XP055126357 [A] 1-21
INTERNATIONAL-SEARCH-REPORT- THOMAS SCHLAKE ET AL, "Developing mRNA-vaccine technologies", RNA BIOLOGY, (20121101), vol. 9, no. 11, doi:10.4161/rna.22269, ISSN 1547-6286, XP055126360 [A] 1-21
OPPOSITION- Anonymous, "GenScript codon usage frequency table chart tool", GenScript, page 1, URL: https://www.genscript.com/tools/codon-frequency-table-
OPPOSITION- ISAACS et al., "Foreign Nucleic Acids as the Stimulus to Make Interferon", The Lancet, (19630000), vol. 282, pages 113 - 116, XP055778454-
OPPOSITION- Jiajie Wei, Ying Zhang, Ivaylo P. Ivanov, Matthew S. Sachs, "The Stringency of Start Codon Selection in the Filamentous Fungus Neurospora crassa", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (20130329), vol. 288, no. 13, doi:10.1074/jbc.M112.447177, ISSN 0021-9258, pages 9549 - 9562, XP055561136
OPPOSITION- WEI et al., "The Stringency of Start Codon Selection in the Filamentous Fungus Neurospora crassa", Journal of Biological Chemistry, (20130000), vol. 288, doi:10.1074/jbc.M112.447177, pages 9549 - 9562, XP055561136
OPPOSITION- Kholiswa C. Ngumbela,Kieran P. Ryan,Rohini Sivamurthy,Mark A. Brockman,Rajesh T. Gandhi,Nina Bhardwaj,Daniel G. Kavanagh, "Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells", PLoS One, (20080000), vol. 3, pages 1 - 5, XP055661944
OPPOSITION- Kholiswa C. Ngumbela, Kieran P. Ryan, Rohini Sivamurthy, Mark A. Brockman, Rajesh T. Gandhi, Nina Bhardwaj, Daniel G. Kavanagh, "Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells", PLoS ONE, vol. 3, no. 6, doi:10.1371/journal.pone.0002356, page e2356, XP055661944
OPPOSITION- FORSBACH A; NEMORIN JG; MONTINO C; MULLER C; SAMULOWITZ U; VICARI AP; JURK M; MUTWIRI GK; KRIEG AM; LIPFORD GB ET AL., "Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses", J IMMUNOL, (20080101), vol. 180, doi:10.4049/jimmunol.180.6.3729, pages 3729 - 3738, XP002775830
OPPOSITION- Karl-Josef Kallen, Regina Heidenreich, Margit Schnee, Benjamin Petsch, Thomas Schlake, Andreas Thess, Patrick Baumhof, Birgit Scheel, Sven D Koch, Mariola Fotin-Mleczek, "A novel, disruptive vaccination technology: Self-adjuvanted RNActive® vaccines", Human vaccines & immunotherapeutics, (20131001), vol. 9, no. 10, doi:10.4161/hv.25181, ISSN 21645515, pages 16 - 29, XP055126357
OTHER- WEI et al., "The Stringency of Start Codon Selection in the Filamentous FungusNeurospora crassa", Journal of Biological Chemistry, (20130329), vol. 288, no. 13, pages 9549 - 9562, XP055561136
OTHER- GALIGER C. et al, "Assessment of Efficacy of Antifungals against Aspergillus fumigatus: Value of Real-Time Bioluminescence Imaging", Journal of Biological Chemistry, (20130711), vol. 57, no. 7, pages 3046 - 3059, XP055561132
OTHER- NGUMBELA et al., "Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells", PLoS One, (20080604), vol. 3, no. 6, page e2356, XP055661944

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents